BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 35583061)

  • 1. [Conditional medium of gastric cancer mesenchymal stem cells promotes PD-L1 expression in gastric cancer cells and tumor growth via upregulating VGLL4].
    Ding Y; Zhu W; Wang Q; Chen B; Wang M; Zhao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Apr; 38(4):321-327. PubMed ID: 35583061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1.
    Li Q; Xiao M; Shi Y; Hu J; Bi T; Wang C; Yan L; Li X
    BMC Cancer; 2021 Sep; 21(1):1022. PubMed ID: 34525951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells.
    Gao Q; Huang C; Liu T; Yang F; Chen Z; Sun L; Zhao Y; Wang M; Luo L; Zhou C; Zhu W
    J Cell Biochem; 2024 Mar; 125(3):e30521. PubMed ID: 38226525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic Value of PCMT1 Expression in Gastric Cancer and Its Regulatory Effect on Spindle Assembly Checkpoints].
    Wang Y; Zhang M; Zhang Z; Li B; Huang J; Li J; Geng Z; Zhang X; Song X; Wang L; Zuo L; Hu J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1167-1175. PubMed ID: 38162070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase HDAC4 promotes gastric cancer SGC-7901 cells progression via p21 repression.
    Kang ZH; Wang CY; Zhang WL; Zhang JT; Yuan CH; Zhao PW; Lin YY; Hong S; Li CY; Wang L
    PLoS One; 2014; 9(6):e98894. PubMed ID: 24896240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric Cancer Mesenchymal Stem Cells Trigger Endothelial Cell Functional Changes to Promote Cancer Progression.
    Cui L; Liu T; Huang C; Yang F; Luo L; Sun L; Zhao Y; Wang D; Wang M; Ji Y; Zhu W
    Stem Cell Rev Rep; 2024 Apr; ():. PubMed ID: 38598065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer.
    Wang X; Deng X; Hu J; Zheng W; Ye D; Zhou X; Fang L
    Cancer Lett; 2024 Apr; 588():216764. PubMed ID: 38431034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formononetin Restrains Tumorigenesis of Breast Tumor by Restraining STING-NF-κB and Interfering with the Activation of PD-L1.
    Liu H; Wang Z; Liu Z
    Discov Med; 2024 Mar; 36(182):613-620. PubMed ID: 38531802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lactate promotes HMGB1 phosphorylation and release via Akt signaling pathway in gastric cancer cells HGC-27].
    Chen XL; Ge F; Wan MQ; Qi SM; Qi ZL
    Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):919-925. PubMed ID: 37968076
    [No Abstract]   [Full Text] [Related]  

  • 10. Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer.
    Lee SY; Jhun J; Woo JS; Lee KH; Hwang SH; Moon J; Park G; Choi SS; Kim SJ; Jung YJ; Song KY; Cho ML
    Gut Microbes; 2024; 16(1):2300846. PubMed ID: 38197259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer.
    Tao LH; Zhou XR; Li FC; Chen Q; Meng FY; Mao Y; Li R; Hua D; Zhang HJ; Wang WP; Chen WC
    Cancer Immunol Immunother; 2017 Mar; 66(3):309-318. PubMed ID: 27889799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Formononetin enhances the antitumor effect of H22 hepatoma transplanted mice].
    Li M; Jiang C; Chen J; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Dec; 39(12):1063-1068. PubMed ID: 38140864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High expression of MRPL13 promotes cell cycle progression and proliferation of gastric cancer cells by inhibiting p53 signaling to affect long-term prognosis].
    Wang L; Xia Y; Zhang Z; Liu X; Shi J; Wang Y; Li J; Zhnag X; Geng Z; Song X; Zuo L
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1558-1566. PubMed ID: 37814870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer.
    Jiang T; Xia Y; Li Y; Lu C; Lin J; Shen Y; Lv J; Xie L; Gu C; Xu Z; Wang L
    Cancer Lett; 2024 Jan; 581():216510. PubMed ID: 38029830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gypenoside induces apoptosis by inhibiting the PI3K/AKT/mTOR pathway and enhances T-cell antitumor immunity by inhibiting PD-L1 in gastric cancer.
    Wu H; Lai W; Wang Q; Zhou Q; Zhang R; Zhao Y
    Front Pharmacol; 2024; 15():1243353. PubMed ID: 38482051
    [No Abstract]   [Full Text] [Related]  

  • 16. Roles of PD-L1 in human adipose-derived mesenchymal stem cells under inflammatory microenvironment.
    Sun J; Zhong H; Kang B; Lum T; Liu D; Liang S; Hao J; Guo R
    J Cell Biochem; 2024 Apr; 125(4):e30544. PubMed ID: 38450777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional factor BRD4 promotes the stemness of esophageal cancer by activating the nuclear PD-L1/RelB axis.
    Li S; Guo Q; Guo R; Xu H
    Environ Toxicol; 2024 Feb; 39(2):669-679. PubMed ID: 37615218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VGLL4 promotes vascular endothelium specification via TEAD1 in the vascular organoids and human pluripotent stem cells-derived endothelium model.
    Quan Y; Hu M; Jiang J; Jin P; Fan J; Li M; Fan X; Gong Y; Yang Y; Wang Y
    Cell Mol Life Sci; 2023 Jul; 80(8):215. PubMed ID: 37468661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer.
    Chakrabarti J; Holokai L; Syu L; Steele NG; Chang J; Wang J; Ahmed S; Dlugosz A; Zavros Y
    Oncotarget; 2018 Dec; 9(100):37439-37457. PubMed ID: 30647844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermia inhibits the progression of gastric cancer by downregulating PLEK2/PD-L1 and possibly participates in immunomodulation.
    Li K; Feng J; Deng J; Shi H; Peng R; Zhang X
    Gene; 2024 Mar; 898():148111. PubMed ID: 38147897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.